Krystal Biotech Stock Price on December 18, 2024
| KRYS Stock | USD 158.52 2.31 1.44% |
Below is the normalized historical share price chart for Krystal Biotech extending back to September 20, 2017. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Krystal Biotech stands at 158.52, as last reported on the 25th of December, with the highest price reaching 162.10 and the lowest price hitting 156.69 during the day.
If you're considering investing in Krystal Stock, it is important to understand the factors that can impact its price. Krystal Biotech has Sharpe Ratio of -0.047, which conveys that the firm had a -0.047% return per unit of risk over the last 3 months. Krystal Biotech exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Krystal Biotech's Mean Deviation of 1.93, standard deviation of 2.66, and Risk Adjusted Performance of (0.04) to check out the risk estimate we provide.
At this time, Krystal Biotech's Total Stockholder Equity is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 859.3 M in 2024, whereas Common Stock is likely to drop (109.7 M) in 2024. . Price Earnings Ratio is likely to gain to 323.56 in 2024, whereas Price To Sales Ratio is likely to drop 72.59 in 2024. Krystal Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 20th of September 2017 | 200 Day MA 179.4603 | 50 Day MA 179.4586 | Beta 0.82 |
Krystal |
Sharpe Ratio = -0.047
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | KRYS |
Estimated Market Risk
| 2.72 actual daily | 24 76% of assets are more volatile |
Expected Return
| -0.13 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Krystal Biotech is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Krystal Biotech by adding Krystal Biotech to a well-diversified portfolio.
Price Book 5.1466 | Enterprise Value Ebitda 21.9685 | Price Sales 18.8768 | Shares Float 22.9 M | Wall Street Target Price 207.7778 |
Krystal Biotech Main Headline on 18th of December 2024
Krystal Biotech Announces Early Evidence of Monotherapy Acti... by finance.yahoo.com
Preliminary clinical data in post-anti-PD-1 NSCLC patients demonstrated a 27 percent ORR and 73 percent DCR in monotherapy trial Monotherapy activity with inhaled KB707 provides further evidence of successful repeat administration of HSV-1 based inhaled lung gene delivery and builds on recent clinical data update for CF and AAT deficiency respiratory disease programs PITTSBURGH, Dec. 18, 2024 -- Krystal Biotech, Inc. , a commercial-stage biotechnology company, an
Krystal Biotech Valuation on December 18, 2024
It is possible to determine the worth of Krystal Biotech on a given historical date. On December 18, 2024 Krystal was worth 176.59 at the beginning of the trading date compared to the closed value of 156.64. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Krystal Biotech stock. Still, in general, we apply an absolute valuation method to find Krystal Biotech's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Krystal Biotech where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Krystal Biotech's related companies.
| Open | High | Low | Close | Volume | |
| 165.76 | 169.66 | 164.32 | 169.04 | 231,777 | |
12/18/2024 | 176.59 | 176.59 | 155.40 | 156.64 | 359,642 |
| 157.52 | 162.39 | 155.16 | 160.83 | 457,599 |
| Backtest Krystal Biotech | | | Krystal Biotech History | | | Krystal Biotech Valuation | Previous | Next |
Krystal Biotech Trading Date Momentum on December 18, 2024
| On December 19 2024 Krystal Biotech was traded for 160.83 at the closing time. The top price for the day was 162.39 and the lowest listed price was 155.16 . The trading volume for the day was 457.6 K. The trading history from December 19, 2024 was a factor to the next trading day price appreciation. The trading delta at closing time against the next closing price was 2.67% . The trading delta at closing time against the current closing price is 2.98% . |
Krystal Biotech Fundamentals Correlations and Trends
By evaluating Krystal Biotech's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Krystal Biotech's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Krystal financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Krystal Biotech Stock history
Krystal Biotech investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Krystal is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Krystal Biotech will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Krystal Biotech stock prices may prove useful in developing a viable investing in Krystal Biotech
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 27.8 M | 18 M | |
| Net Loss | -126 M | -119.7 M |
Krystal Biotech Quarterly Net Working Capital |
|
Krystal Biotech Stock Technical Analysis
Krystal Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Krystal Biotech Period Price Range
Low | December 25, 2024
| High |
0.00 | 0.00 |
Krystal Biotech cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Krystal Biotech December 25, 2024 Market Strength
Market strength indicators help investors to evaluate how Krystal Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Krystal Biotech shares will generate the highest return on investment. By undertsting and applying Krystal Biotech stock market strength indicators, traders can identify Krystal Biotech entry and exit signals to maximize returns
Krystal Biotech Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Krystal Biotech's price direction in advance. Along with the technical and fundamental analysis of Krystal Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Krystal to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.23) | |||
| Total Risk Alpha | (0.28) | |||
| Treynor Ratio | (0.09) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Krystal Stock Analysis
When running Krystal Biotech's price analysis, check to measure Krystal Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Krystal Biotech is operating at the current time. Most of Krystal Biotech's value examination focuses on studying past and present price action to predict the probability of Krystal Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Krystal Biotech's price. Additionally, you may evaluate how the addition of Krystal Biotech to your portfolios can decrease your overall portfolio volatility.